ArticleExperimental & molecular medicine2022

The CDK1/TFCP2L1/ID2 cascade offers a novel combination therapy strategy in a preclinical model of bladder cancer.

Jinbeom Heo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.